Study to Evaluate Laquinimod Compared to Interferon ß-1a Administered by Injection

- Relapsing Remitting Multiple Sclerosis
- Withdrawn

Study Title: A Study to Evaluate 2 Doses Of Oral Administration Of Laquinimod Compared to Interferon ֳŸ-1a Administered by Injection in Participants With Relapsing Remitting Multiple Sclerosis (RRMS)

Teva Identifier: LAQ-MS-306 | 2013-002082-19

ClinicalTrials.gov Identifier: NCT01975298

Study Status: Withdrawn

Trial Condition(s): Relapsing Remitting Multiple Sclerosis

Interventions: Drug: Laquinimod | Drug: Avonexֲ®

Study Description

Please refer to ClinicalTrials.gov for a description of the trial

Participation criteria and map of study locations

Key Participation Requirements

Gender: Female, Male

Age group: Adult

Age Range: 18 Years to 55 Years

Trial Duration: 01/01/2014 - 03/01/2014

Phase: Phase 3

Study Type

Interventional